Introduction {#s1}
============

*Bacillus thuringiensis* (*Bt*) has been extensively studied because of its ability to produce insecticidal proteins during sporulation. The insecticidal properties of these *Bt* proteins have been commercially exploited as biological insecticides [@pone.0081335-Huang1], [@pone.0081335-Pigott1]. Many crystal (Cry) proteins exist as protoxins with a molecular mass of 130 kDa. The activation of the protoxin appears to occur via a sequential series of proteolytic cleavages that begin at the C-terminus and proceed toward the N-terminus until a protease-stable toxin, typically having a molecular mass of 65 kDa, is generated [@pone.0081335-Choma1].

DNA condensation has been observed in the region of crystalline inclusion body formation, which is an important stage for Cry production in *Bt* [@pone.0081335-Bietlot1]. It has been reported that some Cry proteins appear to be complexed with DNA [@pone.0081335-Bietlot1]. For example, a 20-kbp DNA fragment was observed in Cry proteins isolated from seven subspecies of *Bt* and in the Cry1Aa, Cry1Ab, and Cry1Ac proteins cloned and expressed in *Escherichia coli* [@pone.0081335-Clairmont1], [@pone.0081335-Guo1]. Studies have been conducted to determine the form of DNA associated with the Cry1A protoxin, and only the N-terminal toxic moiety of the protoxin has been found to interact with DNA [@pone.0081335-Clairmont1]. Previously, we studied the DNA associated with the activated toxin and speculated that the association of this DNA with the Cry8Ea1 toxin serves to stabilize the protein against aggregation and increases the tendency of the toxin to move toward the phospholipid membrane [@pone.0081335-Guo1].

The mode of action of the Cry protein involves the following steps: solubilization of the crystals in the midgut, protoxin activation by midgut proteases, binding of the activated toxin to the receptors localized in the apical microvilli of insect midgut cells, oligomerization of the toxin, insertion of the toxin into the apical membrane, and pore formation that ultimately kills the cells [@pone.0081335-PardoLpez1]. However, the function of the DNA associated with the activated toxin in the mechanism of action of the Cry toxin has not been determined.

Cry8Ca, a type of Cry protein, is toxic to *Anomala corpulenta* and *A. exoleta* larvae, and Cry8Ea is toxic to *Holotrichia parallela* larvae. All of these insect larvae are important pests in agriculture, horticulture, and forestry [@pone.0081335-Huang1], [@pone.0081335-Ogiwara1]--[@pone.0081335-Shu1]. In the present study, the binding specificities of both forms of the Cry8Ea1 and Cry8Ca2 toxins, i.e., with and without bound DNA, to the midgut of the target insect larvae were compared. The Cry8Ca2 and Cry8Ea1 toxin-DNA complex was isolated, and the role of DNA binding was investigated. Based on the these results, we propose an additional step in the mechanism of action of the Cry8 toxin and elucidate the function of the associated DNA as well as the importance of the removal of this DNA for the insecticidal activity of the toxin.

Materials and Methods {#s2}
=====================

Materials {#s2a}
---------

The bacterial strain *Bt* HBF-1, which contains the *cry8Ca2* gene (accession No. AY518201) that encodes the Cry8Ca2 protoxin [@pone.0081335-Shu1], was obtained from the Institute of Plant Protection, Hebei Academy of Agricultural and Forestry Sciences, Baoding, China.

The *Bt* strain HD8E with the plasmid pSTK-8E, which contains the *cry8Ea1* gene (GenBank accession No. AY329081) that encodes the Cry8Ea1 protoxin, was developed and stored at the State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences [@pone.0081335-Shu2], [@pone.0081335-Shu3].

Superdex 200, Resource-Q, and Sephadex G-50 columns were obtained from Amersham Pharmacia Biotech, and ultra-centrifuge filters were purchased from Millipore. DNase I (RNase-free) was purchased from Takara. CHES and Triton X-100 were obtained from Amresco. Egg-yolk phosphatidyl choline (PC) was purchased from Avanti Polar Lipids (Alabaster, AL), and calcein was obtained from Molecular Probes (Eugene, OR).

Proteinase K, TPCK-treated trypsin, bovine pancreas α-chymotrypsin, cholesterol (Ch), and stearylamine (S) were purchased from Sigma. All other reagents were local products of analytical grade.

Purification of the Cry8 toxin and Cry8 toxin-DNA complex {#s2b}
---------------------------------------------------------

The Bt HBF-1 strain was grown at 30°C in PB medium (0.5% peptone and 0.3% beef extract) for approximately 54 h. The Bt HD8E strain was grown, and the protoxin was obtained as previously described [@pone.0081335-Guo2]. Cell harvesting and crystal purification were performed according to the procedure described by Luo *et al*. [@pone.0081335-Luo1]. The purification of the Cry8Ca2 toxin, Cry8Ca2 toxin-DNA complex, Cry8Ea1 toxin, and Cry8Ea1 toxin-DNA complex was performed according to a previously described method for Cry8Ea1 [@pone.0081335-Guo1]. Briefly, the Cry toxin-DNA complex was obtained by initial activation of the protoxin with chymotrypsin followed by purification using size-exclusion chromatography with a Superdex 200 column (HR 10/30) equilibrated with 50 mM Na~2~CO~3~ (pH 10.2) using a Pharmacia FPLC system. The Cry toxin-DNA complex was further treated with DNase I (1 U/mg toxin) at 4°C for 12 h. The Cry toxin without DNA was obtained by a second application to the Superdex 200 column using the same buffer and parameters described above.

Determination of the surface pressure caused by the penetration of the protein into the air/water interface {#s2c}
-----------------------------------------------------------------------------------------------------------

The surface pressure of various protein solutions was measured using the Wilhelmy plate method [@pone.0081335-Demel1] with a NIMA 9000 microbalance (Nima Technology Ltd.; Coventry, UK) as described by Xia and Sui [@pone.0081335-Xia1]. The Cry8Ca2 toxin or toxin-DNA complex was added to a 50 mM Na~2~CO~3~ (pH 10.2) solution to a final concentration of 0.45 mM. We used this high concentration of toxin to get a surface pressure that keeps almost no significant change while further increase the concentration of the toxin. The change in the surface pressure caused by the penetration of the protein into the air/water interface was measured until a stable reading was obtained.

Preparation of small unilamellar vesicles (SUVs) and loading of the liposomes with calcein {#s2d}
------------------------------------------------------------------------------------------

The SUV preparation was performed as previously described [@pone.0081335-RodriguezAlmazan1]. Briefly, egg-yolk phosphatidyl choline (PC), cholesterol (Ch), and stearylamine (S) were mixed in glass vials in a 7∶1∶2 proportion (µmol), respectively, to a final concentration of 2.6 mol and dried by argon flow evaporation followed by overnight storage under vacuum to remove any residual chloroform. The lipids were hydrated in 2.6 ml of a solution of 10 mM CHES and 150 mM KCl pH 9 for 5 min followed by vortexing. To prepare the SUVs, the lipid suspension was subjected to sonication three times for 2 min using a Branson-1200 bath sonicator. The SUVs were used within 2 -- 3 d after their preparation.

Calcein-containing liposomes were prepared by sonication (three times for 2 min) of the SUVs in calcein (80 mM) dissolved in 150 mM KCl and 10 mM CHES, pH 9, as previously described [@pone.0081335-RodriguezAlmazan1]. Non-entrapped calcein was removed by gel filtration on Sephadex G-50 (1×15 cm column) eluted with the same buffer.

Calcein-release assays {#s2e}
----------------------

Calcein leakage experiments were performed as previously described [@pone.0081335-RodriguezAlmazan1], [@pone.0081335-Rausell1]. Calcein-loaded SUVs (100 µl) were added to 900 µl of a solution of 150 mM KCl and CHES 10 mM, pH 9, in a glass tube. Calcein fluorescence was excited at 490 nm (2 nm slit) and monitored at 520 nm using a Fluoromax-4 spectrofluorometer (Horiba Jobin Yvon). Finally, different freshly prepared Cry toxins (20 nM) were added to the SUVs and incubated for 20 min. The released calcein induced an increase in fluorescence due to the dequenching of the dye in the external medium. Maximal leakage at the end of each experiment was assessed by lysis with 0.1% Triton X-100 (final concentration). All fluorescence experiments were performed in quadruplicate at 20°C.

Preparation of brush border membrane vesicles (BBMVs) {#s2f}
-----------------------------------------------------

The BBMVs were prepared from the midguts of third instar larvae of *A. corpulenta* and *H. parallela* using the differential magnesium precipitation method described by Wolfersberger *et al*. [@pone.0081335-Wolfersberger1]. Leucine aminopeptidase was used as a marker of membrane proteins during BBMV preparation as previously described [@pone.0081335-Garczynski1]. The enrichment of Leucine aminopeptidase activity in BBMV preparations ranged from 10 to 15 fold relative to that in crude homogenates. The prepared BBMVs were stored as aliquots at −80°C.

Competition binding assays {#s2g}
--------------------------

The Cry8Ea1 toxin and toxin-DNA complex were biotinylated using a protein biotinylation kit (Sigma-Aldrich) according to the manufacturer\'s protocol. The molar ratio in the reaction mixture is ∼13∶1 of biotinylation reagent (BAC-SulfoNHS) to protein.

Briefly, 20 µg of BBMV proteins from *A. corpulenta* or *H. parallela* larvae was incubated with 10 nM biotinylated toxin in the presence or absence of a 50- to 1,000-fold excess of unlabeled toxin in binding buffer (PBS, 0.1% w/v bovine serum albumin, 0.1% v/v Tween 20 at pH 7.6) for 1 h. The unbound toxin was removed by centrifugation for 10 min at 14,000 *g*. The BBMVs were suspended in 100 µl of binding buffer and washed twice with the same buffer. Finally, the BBMVs were suspended in 20 µl of PBS (pH 7.6), and an equal volume of 2× Laemmli sample loading buffer (0.125 M Tris-HCl, pH 6.8, 4% sodium dodecyl sulfate, 20% glycerol, 10% 2-mercaptoethanol, and 0.01% bromophenol blue) was added. The samples were boiled for 5 min, loaded onto SDS-PAGE gels, and electrotransferred to PVDF membranes [@pone.0081335-Padilla1]. The biotinylated protein that remained bound to the vesicles was visualized by incubation with ExtrAvidin-Peroxidase conjugate (1∶10,000 dilution) for 1 h, followed by color development with the ECL Western Blotting Substrate (Pierce), according to the manufacturer\'s protocol.

Bioassay {#s2h}
--------

Solutions of Cry8Ea1 toxin or toxin-DNA complex were diluted in 50 mM Na~2~CO~3~ (pH 10.2) as a series of gradient concentrations and then mixed at a ratio of 40∶200 (ml/g) with soil containing 20 15-d larvae of *H. parallela* and their foodstuff (ultraviolet-sterilized potato pieces) as previously described [@pone.0081335-Yu1]. As the negative control, solutions without the toxins were added to the same soil. All bioassays were conducted at 25°C with a soil humidity of 18 -- 20%. Each assay was repeated three times to reduce bias. The larval mortality was scored after incubation for 7 and 14 d to calculate the 50% lethal concentration (LC~50~) of Cry8Ea1 toxin based on probit analysis [@pone.0081335-Finney1].

Digestion of the Cry8Ea1 toxin and toxin-DNA complex by Proteinase K {#s2i}
--------------------------------------------------------------------

The Cry8E toxin and toxin-DNA complex were digested with different amounts of proteinase K (1∶5, 1∶10, 1∶20, 1∶30, 1∶40 and 1∶50, weight/weight) in 50 mM Na~2~CO~3~ at 37°C for 5 min. Subsequently, phenylmethylsulfonyl fluoride (PMSF) was added to a final concentration of 1 mM to stop the proteolysis. Quantitation of the 65 kDa toxin bands was performed by densitometry analysis using BandScan 4.5 software from Glyko (<http://www.glyko.com/BandScan/Features.html>).

Results {#s3}
=======

The presence of DNA associated with the Cry8Ca2 protoxin and the activated toxin {#s3a}
--------------------------------------------------------------------------------

The isolated Cry8Ca2 protoxin was analyzed by SDS-PAGE and agarose gel electrophoresis ([Fig. 1](#pone-0081335-g001){ref-type="fig"}). Similar to many other Cry proteins, the observed molecular mass of the Cry8Ca2 protoxin was approximately 130 kDa, and it could be activated into the 65-kDa toxin by chymotrypsin ([Fig. 1A](#pone-0081335-g001){ref-type="fig"}). An approximately 20-kbp DNA fragment was associated with the protoxin. This DNA fragment appeared to be susceptible to nuclease attack, and digestion with DNase I at 37°C for 1 h eliminated most of the DNA ([Fig. 1B](#pone-0081335-g001){ref-type="fig"}). After DNase I digestion, the protoxin could still be activated into the 65-kDa toxin by trypsin or chymotrypsin ([Fig. 1C](#pone-0081335-g001){ref-type="fig"}). The initial treatment of the Cry8Ca2 protoxin with DNase I followed by digestion with chymotrypsin or trypsin also resulted in a 20-kbp DNA fragment, which was detected associated with the toxin ([Fig. 1D](#pone-0081335-g001){ref-type="fig"}).

![The Cry8Ca2 protoxin-DNA complex.\
A. Electrophoretic analysis of the Cry8Ca2 protoxin by SDS-PAGE. Lane 1, molecular mass marker; Lane 2, Cry8Ca2 protoxin; and Lane 3, digestion of Cry8Ca2 with chymotrypsin (1∶50, w/w) at 37°C for 1 h. B. The association of DNA with the Cry8Ca2 protoxin. Lane 1, DNA Marker (λ DNA/*Eco*130I: 19329, 7743, 6223, 4254, 3472, 2690, 1882, 1489, 925, and 421 bp); Lane 2, DNA associated with the Cry8Ca2 protoxin; and Lane 3, DNA detection after DNase I treatment at 37°C for 1 h. C. Electrophoretic analysis of the Cry8Ca2 protein by SDS-PAGE after DNase I treatment. Lane 1, molecular mass marker; Lane 2, Cry8Ca2 protoxin; Lane 3, Cry8Ca2 protoxin after DNase I treatment at 37°C for 1 h; Lane 4, further digestion of the Cry8Ca2 protoxin by chymotrypsin (1∶ 50, w/w) at 37°C for 1 h after DNase I treatment; and Lane 5, further digestion of the Cry8Ca2 protoxin by trypsin (1∶50, w/w) at 37°C for 1 h after DNase I treatment. D. Electrophoretic analysis of the Cry8Ca2-DNA complex after DNase I and trypsin digestion. Lanes 1--3 corresponded to lanes 1-3 in B; Lanes 4--5, further digestion of the Cry8Ca2 protoxin by trypsin (1∶30 and 1∶50, w/w) at 37°C for 1 h after DNase I treatment; Lanes 6--7, further digestion of the Cry8Ca2 protoxin by chymotrypsin (1∶30 and 1∶50, w/w) at 37°C for 1 h after DNase I treatment; Lane 8, digestion of the Cry8Ca2 protoxin by proteinase K (final concentration, 50 µg/ml).](pone.0081335.g001){#pone-0081335-g001}

After activation by chymotrypsin, either ion-exchange chromatography (Resource-Q) or size exclusion chromatography (Superdex 200) was used to obtain the purified Cry8Ca2 toxin ([Fig. 2](#pone-0081335-g002){ref-type="fig"}). In ion-exchange chromatography ([Fig. 2A1](#pone-0081335-g002){ref-type="fig"}), the Cry8Ca2 toxin was eluted at between 0.2 M -- 0.6 M NaCl, as indicated in peak 1 ([Fig. 2A2](#pone-0081335-g002){ref-type="fig"}), and was detected without DNA association ([Fig. 2A3, Lane 3](#pone-0081335-g002){ref-type="fig"}). Using size exclusion chromatography, the peak fraction indicated by the arrow ([Fig. 2B1](#pone-0081335-g002){ref-type="fig"}) was determined to be the fraction containing Cry8Ca2 ([Fig. 2B2, Lane 2](#pone-0081335-g002){ref-type="fig"}), which was found to contain bound DNA ([Fig. 2B3, Lane 2](#pone-0081335-g002){ref-type="fig"}). After DNase I digestion, the Cry8Ca2 toxin without DNA was obtained after a second application to the Superdex 200 column ([Fig. 2B2, lane 1](#pone-0081335-g002){ref-type="fig"}; [Fig. 2B3, lane 1](#pone-0081335-g002){ref-type="fig"}).

![Electrophoretic analysis of the purified Cry8Ca2 toxin and toxin-DNA complex.\
A. Cry8Ca2 toxin purified using Resource-Q. A1. Elution profile of the Cry8Ca2 toxin. Peak 1 is the fraction containing the Cry8Ca2 toxin. A2. Electrophoretic analysis of the Cry8Ca2 toxin by SDS-PAGE. Lane 1, purified Cry8Ca2 toxin. A3. DNA analysis by 0.7% agarose gel electrophoresis. Lane 1, DNA associated with Cry8Ca2 protoxin. Lane 2, DNA associated with the Cry8Ca2 toxin after chymotrypsin digestion. Lane 3, peak 1 fraction of the Cry8Ca1 toxin. Lane 4, peak 2 fraction of the Cry8Ca1 toxin. B. Cry8Ca2 toxin purified using Superdex 200. B1. Elution profile of the Cry8Ca2 toxin-DNA complex. The peak indicated by the arrow is the fraction containing the Cry8Ca1 toxin-DNA complex. B2. Electrophoretic analysis of the Cry8Ca2 toxin and Cry8Ca2 toxin-DNA by SDS-PAGE. Lane 1, purified Cry8Ca2 toxin (peak fraction of B1 digested with DNase I and collected using Superdex 200) and Lane 2, purified Cry8Ca2 toxin-DNA complex (peak fraction of B1). B3. Analysis of the DNA associated with the Cry8Ca2 toxin and the Cry8Ca2 toxin-DNA complex using 0.7% agarose gel electrophoresis. Lane M, DNA Marker (λ DNA/*Eco*130I); Lane 1, DNA preparation from the Cry8Ca2 toxin; and Lane 2, DNA associated with the Cry8Ca2 toxin-DNA complex.](pone.0081335.g002){#pone-0081335-g002}

Two aliquots of the Cry8Ca2 toxin, one that was freshly purified and another that had been stored at 4°C for 5 d, were applied to the Superdex 200 column. Identical procedures were performed for the Cry8Ca2 toxin-DNA complex. The elution profiles are shown in [Fig. 3](#pone-0081335-g003){ref-type="fig"}. The Cry8Ca2 toxin and toxin-DNA complex had identical elution volumes, indicating that they have a similar molecular size. After storage, most of the Cry8Ca2 toxin aggregated into high molecular weight multimers (the peak indicated by the arrow in [Fig. 3A](#pone-0081335-g003){ref-type="fig"}), whereas only a small amount of the Cry8Ca2 toxin-DNA complex had aggregated (the peak indicated by the arrow in [Fig. 3B](#pone-0081335-g003){ref-type="fig"}).

![Size exclusion chromatography elution profiles of the Cry8Ca2 toxin and Cry8Ca2 toxin-DNA complex comparing the freshly purified protein with that stored at 4°C for 5 d.\
A. Elution profiles of the Cry8Ca2 toxin. Profile a is the elution profile of the freshly purified Cry8Ca2 toxin, whereas profile b corresponds to the protein stored at 4°C for 5 d. B. Elution profiles of the Cry8Ca2 toxin-DNA complex. Profile a is the elution profile of the freshly purified Cry8Ca2 toxin-DNA complex, whereas profile b corresponds to that of the protein stored at 4°C for 5 d.](pone.0081335.g003){#pone-0081335-g003}

Penetration of the toxin into the air/water interface {#s3b}
-----------------------------------------------------

The penetration of the Cry8Ca2 toxin and Cry8Ca2 toxin-DNA complex into the air/water interface without the phospholipid was measured. The results ([Fig. 4](#pone-0081335-g004){ref-type="fig"}) indicate that the maximum Δπ value induced by the Cry8Ca2 toxin was 7.6 mN/m ([Fig. 4A](#pone-0081335-g004){ref-type="fig"}), whereas the maximum Δπ value induced by the Cry8Ca2 toxin-DNA complex was 13.9 mN/m ([Fig. 4B](#pone-0081335-g004){ref-type="fig"}). There was about 2 fold difference between the data, which indicate that the Cry8Ca2 toxin-DNA complex is more likely to move toward the air/water interface and is more hydrophobic than the toxin without DNA.

![Analyses of the surface pressure caused by the penetration of the protein into the air/water interface and the pore-forming activity based on calcein-release assays.\
A. The surface pressure of the Cry8Ca2 toxin. B. The surface pressure of the Cry8Ca2 toxin-DNA complex. The final protein concentration was 0.45 mM in a solution of 50 mM Na~2~CO~3~ at pH 10.2. C and D. Analysis of the pore-forming activity using calcein-release assays. Calcein-loaded SUVs were incubated with various protein preparations (final concentration of 20 nM), and the release of calcein was analyzed. The maximal leakage at the end of each experiment was measured by the addition of 0.1% Triton X-100. Each value represents the mean ± SD of four replicate experiments. Bovine serum albumin (BSA) was used as a negative control. A t-test was used to analyze statistical differences of mean values of the percentage of calcein released by the toxin or its toxin-DNA complex when compared with control. Bars labeled with different letters inside each figure indicate that the differences were statistically significant (P\<0.001).](pone.0081335.g004){#pone-0081335-g004}

Pore-forming ability of Cry8 toxin and its toxin-DNA complex analyzed by calcein-release assays {#s3c}
-----------------------------------------------------------------------------------------------

We analyzed the pore-forming ability of the Cry8 toxin and its toxin-DNA complex using SUV liposomes and calcein-release assays. Calcein-containing SUVs were prepared, and the integrity of the lipid membrane vesicles was determined after the addition of the toxins. The release of entrapped calcein from the SUVs was measured as dequenching of the calcein fluorescence and was thereby monitored continuously as an increase in the fluorescence intensity [@pone.0081335-RodriguezAlmazan1]. The data are expressed as a percentage of the maximal fluorescence release obtained using Triton X-100 treatment as the positive control. As shown in [Fig. 4](#pone-0081335-g004){ref-type="fig"} (C and D), the Cry8 toxin and its toxin-DNA complex, including both Cry8E and Cry8C, can cause the release of calcein from the interior of the SUVs. The Cry8E and Cry8C toxins showed a similar extent of calcein release at approximately 90% release, which was greater than that of the toxin-DNA complexes. These findings indicate that both the Cry8 toxin and its toxin-DNA complex were able to form pores and affect the integrity of the SUV liposomes, but that the toxin without DNA showed a stronger ability than did the corresponding toxin-DNA complex. By t-test, it was confirmed that the difference of the pore-forming ability between the Cry8 toxin and its toxin-DNA complex was statistically significant.

Competitive binding assays {#s3d}
--------------------------

The binding of the Cry8Ca2 toxin and toxin-DNA complex to the BBMVs of the *A. corpulenta* larvae in addition to the binding of the Cry8Ea1 toxin and toxin-DNA complex to the BBMVs of the *H. parallela* larvae were analyzed using competitive binding assays. The results of the homologous and heterologous binding of the Cry toxin and toxin-DNA complex to the BBMVs are shown in [Fig. 5](#pone-0081335-g005){ref-type="fig"}. In the homologous competitive binding assay, an excess amount of unlabeled Cry8Ea1 toxin or Cry8Ca2 toxin inhibited the binding of the biotinylated Cry toxin to the BBMVs of the target insect. The homologous competitive binding profile indicated that the Cry8Ea1 toxin specifically bound to the BBMVs of the *H. parallela* larvae, whereas the Cry8Ea1 toxin-DNA complex bound nonspecifically to these BBMVs ([Fig. 5A](#pone-0081335-g005){ref-type="fig"}). Similarly, the Cry8Ca2 toxin specifically bound to the BBMVs of the *A. corpulenta* larvae, whereas the Cry8Ca2 toxin-DNA complex bound nonspecifically to these vesicles ([Fig. 5B](#pone-0081335-g005){ref-type="fig"}). Commercial calf thymus DNA was added to the Cry8E or Cry8C toxin under the homologous competitive binding conditions as a control for external DNA, and the result indicated that external DNA does not interfere with the specific binding. The profile of heterologous competitive binding indicated that the biotinylated Cry toxin-DNA complex does not compete with the Cry toxin while binding to the BBMVs of the insect. This result suggests that the Cry toxin, but not the Cry toxin-DNA complex, specifically recognizes the receptor in the midgut of the target insect.

![Competitive binding assays of the Cry8 toxin and toxin-DNA complex using the BBMVs from the target larvae.\
A. Competitive binding of the Cry8Ea1 toxin and Cry8Ea1 toxin-DNA complex with the BBMVs of *H. parallela* larvae. B. Competitive binding of the Cry8Ca2 toxin and Cry8Ca2 toxin-DNA complex with the BBMVs of *A. corpulenta* larvae. Lane 1, homologous competitive binding of the Cry toxin and biotinylated Cry toxin; Lane 2, homologous competitive binding of the Cry toxin-DNA complex and biotinylated Cry toxin-DNA complex; Lane 3, heterologous competitive binding of the Cry toxin-DNA complex and biotinylated Cry toxin; and Lane 4, homologous competitive binding of the Cry toxin and its biotinylated Cry toxin plus calf thymus DNA (0.2 µg in each 100-µl aliquot of competitive binding reaction) as an external DNA control.](pone.0081335.g005){#pone-0081335-g005}

The LC~50~ of the Cry8Ea1 with or without DNA against the *H. parallela* larvae was determined using laboratory bioassays. The LC~50~ of the Cry8E toxin was 57.50 (25.84 -- 341.22) µg/g soil and that of the Cry8E toxin-DNA complex was 47.59 (31.42 -- 84.21) µg/g soil. Their 95% fiducial limits partially overlapped.

Digestion of the toxin-DNA complex by the midgut juices of the target insects and proteinase K {#s3e}
----------------------------------------------------------------------------------------------

To determine whether the bound DNA fragment of the Cry8Ea1 toxin can be degraded by the insect, the midgut juice was obtained from *H. parallela* larvae, and the extent of digestion was evaluated. The results showed that the DNA fragment can be degraded by the diluted midgut juice in a manner similar to the degradation observed by commercially available DNase I ([Fig. 6](#pone-0081335-g006){ref-type="fig"}).

![Agarose gel electrophoresis detection of the digestion products of the Cry8E toxin-DNA complex by midgut juice from *H. parallela* larvae.\
Lane 1, the Cry8E toxin-DNA complex; Lane 2, the Cry8E toxin-DNA complex digested using DNase I at 37°C for 1 h; Lane 3, 0.25% midgut juice; Lanes 4--7, the Cry8E toxin-DNA complex digested using 0.25% midgut juice using 1 µl, 2 µl, 3 µl, and 4 µl, respectively, at 37°C for 1 h.](pone.0081335.g006){#pone-0081335-g006}

Proteinase K digestion was performed to determine whether the bound DNA of the Cry toxin protects the Cry protein from proteolytic digestion. A titration of the proteinase K concentration was performed in which the Cry8Ea1 toxin and Cry8Ea1 toxin-DNA complex were digested under identical conditions at 37°C for 5 min; the results of this test are shown in [Fig. 7](#pone-0081335-g007){ref-type="fig"}. The 65-kDa toxin band was quantified by densitometry analysis, with lane 8 considered to be 100%. As shown in [Fig. 7](#pone-0081335-g007){ref-type="fig"}, the residual amount of the 65-kDa toxins under different proteolytic digestion conditions varied with increasing concentrations of proteinase K, and the proteolytic system with the Cry8Ea1 toxin-DNA complex had a higher amount of the 65-kDa toxin remaining relative to the toxin without DNA. The values between them were significantly different (P\<0.01) by t-test. This result indicated that the bound DNA fragment of the Cry8Ea1 toxin provides a certain extent of protection of the Cry protein against proteolytic digestion.

![SDS-PAGE analysis of the digestion products of the Cry8E toxin and Cry8E toxin-DNA complex by proteinase K at 37°C for 5 min.\
A. Digestion of the Cry8E toxin by proteinase K. B. Digestion of the Cry8E toxin-DNA complex by proteinase K. Lane 1, molecular mass marker; Lanes 2--7, products of the digestion of the toxin or toxin-DNA complex by proteinase K at protein (weight/weight) ratios of 1∶5, 1∶10, 1∶20, 1∶30, 1∶40, and 1∶50, respectively; Lane 8A, the Cry8E toxin; and Lane 8B, the Cry8E toxin-DNA complex. A t-test was used to analyze statistical differences of the mean values of the digestion products of the Cry8E toxin-DNA complex by Proteinase K when compared with the Cry8E toxin, as indicated in the right table.](pone.0081335.g007){#pone-0081335-g007}

Discussion {#s4}
==========

Previous studies have shown that the DNA bound to Cry is not an artifact of the crystal purification procedure but is an integral component of the crystal that specifically interacts with the protoxin [@pone.0081335-Bietlot1], [@pone.0081335-Clairmont1]. Clairmont *et al*. proposed a virus-like structure for the DNA-protoxin complex, described as having a central DNA core surrounded by proteins that interact with the DNA and peripheral ends of the C-terminal region that extend outward [@pone.0081335-Clairmont1]. This structure is not supported by the results obtained for Cry8Ea1 and Cry8Ca2 in this present study.

Consistent with the results obtained for Cry8Ea1 [@pone.0081335-Guo1], the data obtained for Cry8Ca2 indicate that two different DNA fragments were associated with the protoxin: one fragment is susceptible to nuclease attack, likely because it is relatively more exposed, and the second fragment cannot be detected until the protoxin is activated by trypsin or chymotrypsin. The second DNA fragment is associated with the activated toxin. Clairmont *et al*. also demonstrated that protoxin interacts with the DNA via the N-terminal toxic moiety [@pone.0081335-Clairmont1]. Our research focused on the DNA-activated toxin complex. The analysis using size exclusion chromatography indicated no obvious differences between the elution volumes of the purified Cry8Ca2 toxin and toxin-DNA complex, which was also observed for the Cry8Ea1 toxin and toxin-DNA complex [@pone.0081335-Guo1]. Typically, the retention time in size exclusion chromatography should be different for samples that are bound to DNA compared with those free of DNA, especially if the bound molecule is a large DNA fragment. However, the similar elution volumes of the purified Cry8 toxin and Cry8 toxin-DNA indicate that the toxin has a similar size with or without DNA. These results imply that the Cry8 toxin-DNA complex possesses a relatively compact structure compared with Cry8Ea1 and Cry8Ca2. Based on these results, we propose that the structure of the activated toxin may differ before and after the digestion of the bound DNA: when bound to DNA, the activated toxin possesses a tight and compact structure, and upon removal of the constraints imposed by the DNA, the toxin changes to a relaxed structure.

Previously, we proposed that DNA associated with the Cry8Ea1 toxin serves to stabilize the protein from aggregation and increases the tendency of the toxin to move toward the phospholipid membrane [@pone.0081335-Guo1]. Consistent with the results obtained for the Cry8Ea1 toxin-DNA complex, the Cry8Ca2 toxin-DNA complex is more likely to move toward the air/water interface and is more hydrophobic than the toxin without DNA, indicating that the Cry8Ca2 toxin-DNA complex might increase the tendency of the toxin to move toward the phospholipid membrane. In addition, the results obtained for the Cry8Ca2 toxin-DNA complex confirmed that the associated DNA protects the toxin from nonspecific aggregation. The pore-forming ability of the Cry8E and Cry8C toxins with or without DNA was assessed based on calcein-release assays using SUV liposomes. After removing the associated DNA, both the Cry8E and Cry8C toxins had a stronger pore-forming ability. The associated DNA makes the structure of Cry8 toxin tight and compact, which might influence the pore-forming ability of the toxin. Although the Cry8 toxin-DNA complex is more hydrophobic than the toxin without DNA, the pore-forming ability, whether strong or not, actually is not determined only by its hydrophobic nature.

The interaction of the Cry toxin with different membrane proteins, such as cadherin-like proteins (CAD), aminopeptidase N (APN), and alkaline phosphatase (ALP), is an important process in the mode of action of the Cry toxin [@pone.0081335-Pigott1], [@pone.0081335-Sobern1]. Our results from the competitive binding assays indicated that the association of DNA with the toxin rendered the toxin unable to specifically bind its target receptor from the midgut of the insect. After removal of the DNA from the toxin-DNA complex by DNase I, the Cry8Ea1 toxin specifically bound to its target in the midgut of the insect. Many studies have focused on the interaction of the Cry toxin with insect BBMVs, and most have shown that the Cry toxin interacts with BBMVs specifically, with clear competition of the unlabeled toxin with the toxin-binding sites using standard methods; however, these methods do not account for bound DNA nor make any provision for removing DNA [@pone.0081335-Higuchi1]--[@pone.0081335-ZigaNavarrete1]. In our previous research, no DNA could be detected in the toxin obtained in the main elution peak from the Resource-Q column before or after phenol/chloroform extraction ([Fig. 2A](#pone-0081335-g002){ref-type="fig"}). In the other studies, the Cry toxin was purified by anion-exchange chromatography [@pone.0081335-Higuchi1]--[@pone.0081335-ZigaNavarrete1], and thus the obtained Cry toxin might also be lacking DNA.

The bioassay results indicated that the DNA had no obvious influence on the insecticidal activity of Cry8Ea1 toxin. Because we determined that the DNA associated with the Cry8Ea1 toxin can be eliminated by the target midgut juice, the DNA will not interfere with the final specific binding of the toxin with its target in BBMVs.

Our findings support our previous supposition that DNA associated with the *Bt* Cry toxin serves to stabilize the protein from aggregation and increases the tendency of the toxin to move toward the phospholipid membrane. In this work, the presence of a DNA fragment in the Cry8Ea1 toxin-DNA complex was confirmed to protect the Cry protein against digestion by proteases. Furthermore, based on the competitive binding and midgut juice digestion assays, we propose that after the toxin-DNA complex arrives at the BBMVs of the insect, the role of the DNA is fulfilled, and the associated DNA is then digested by the DNases present in the midgut, thereby releasing the toxin from the compact structure and allowing it to be recognized by its receptor. Subsequently, according to the previously reported mechanism of action, the activated toxin binds to the receptors localized in the apical microvilli of the insect midgut cells; after certain conformational changes and oligomerization, the toxin inserts into the membrane to form cation-permeable pores, which cause the swelling and death of epithelial cells by colloid-osmotic lysis [@pone.0081335-Schnepf1].

In conclusion, we propose a supplemental step in the mode of action of the Cry8 toxin ([Fig. 8](#pone-0081335-g008){ref-type="fig"}), which emphasizes the presence of DNA associated with the activated toxin and requires the elimination of the DNA for the insecticidal activity of the toxin. Accordingly, variations in the DNase activity in insects may also result in tolerance to the Cry toxin, which requires further investigation. The presence and role of DNA in other Cry toxins should be further analyzed.

![The mechanism of action of the Cry toxin including the proposed role of the toxin-bound DNA.](pone.0081335.g008){#pone-0081335-g008}
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